Prism secures shareholder approval to raise INR 66.5 billion through a public offering. Learn more about this significant ...

Oyo-parent Prism is heading towards the largest travel IPO in India. But its history shows that there is no certainty until ...

OYO's parent PRISM secures shareholder approval to raise ₹6,650 crore via IPO, marking a key step toward public listing.

PRISM, parent of OYO, gets shareholder nod for ₹6,650 crore IPO and bonus issue. Learn about its growth, new name, and future ...

For additional insights and detailed analysis on investing when bubbles may be on the horizon, download the full issue, Prism: 2026 First Half Outlook: Investing amid AI exuberance. Published twice a ...

Prism, the parent company of Oyo, has received shareholder approval to raise up to Rs 6,650 crore through an initial public offering (IPO).

Talus Bioscience, Inc. ("Talus Bio"), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM BioLab Co., Ltd. ("PRISM") to accelerate the discovery and ...

PRISM BioLab, Co. Ltd. ("PRISM") and Talus Bioscience, Inc. ("Talus Bio") announced today that they entered into a collaboration to discover novel Inhibitors of transcription factor (TF) and ...